# Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer

> **NCT00003080** · PHASE1 · COMPLETED · sponsor: **Fred Hutchinson Cancer Center**

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** endocrine-modulating drug therapy
- **DRUG:** melphalan
- **DRUG:** mitoxantrone hydrochloride
- **DRUG:** tamoxifen citrate
- **DRUG:** thiotepa
- **PROCEDURE:** peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00003080
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-09
- **Primary completion:** 2001-05
- **Final completion:** 2001-05
- **Target enrollment:** — (—)
- **Last updated:** 2010-09-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003080, "Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00003080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*